Panitumumab interaction with<scp>TAS</scp>‐102 leads to combinational anticancer effects via blocking of<scp>EGFR</scp>‐mediated tumor response to trifluridineYuji Baba, Kazuhide Nakamura|Molecular Oncology|2017Cited by 22